iTeos Therapeutics (ITOS)
NASDAQ:ITOS
US Market
Holding ITOS?
Track your performance easily

iTeos Therapeutics (ITOS) Technical Analysis

176 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
iTeos Therapeutics’s (ITOS) Moving Averages Convergence Divergence (MACD) indicator is -0.45, suggesting iTeos Therapeutics is a Sell.
iTeos Therapeutics’s (ITOS) 20-Day exponential moving average is 9.27, while iTeos Therapeutics’s (ITOS) share price is $9.27, making it a Sell.
iTeos Therapeutics’s (ITOS) 50-Day exponential moving average is 10.75, while iTeos Therapeutics’s (ITOS) share price is $9.27, making it a Sell.

iTeos Therapeutics (ITOS) Pivot Points

Nov 09, 2024, 12:35 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.32
8.66
8.92
9.26
9.52
9.86
10.12
Fibonacci
8.66
8.89
9.03
9.26
9.49
9.63
9.86
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

iTeos Therapeutics (ITOS) Moving Averages

Nov 09, 2024, 12:35 PM
Period
Simple
Exponential
MA5
9.21Buy
9.17Buy
MA10
8.94Buy
9.08Buy
MA20
9.07Buy
9.27Sell
MA50
10.99Sell
10.75Sell
MA100
13.49Sell
12.15Sell
MA200
13.14Sell
12.08Sell
iTeos Therapeutics’s (ITOS) 10-Day exponential moving average is 9.08, while iTeos Therapeutics’s (ITOS) share price is $9.27, making it a Buy.
iTeos Therapeutics’s (ITOS) 100-Day exponential moving average is 12.15, while iTeos Therapeutics’s (ITOS) share price is $9.27, making it a Sell.
iTeos Therapeutics’s (ITOS) stock price is $9.27 and iTeos Therapeutics’s (ITOS) 50-day simple moving average is 10.99, creating a Sell signal.
iTeos Therapeutics’s (ITOS) stock price is $9.27 and iTeos Therapeutics’s (ITOS) 100-day simple moving average is 13.49, creating a Sell signal.
iTeos Therapeutics’s (ITOS) stock price is $9.27 and iTeos Therapeutics’s (ITOS) 200-day simple moving average is 13.14, creating a Sell signal.

iTeos Therapeutics (ITOS) Technical Indicators

Nov 09, 2024, 12:35 PM
Name
Value
Implied Action
RSI (14)
44.92
Neutral
STOCH (9,6)
71.00
Neutral
STOCHRSI (14)
67.91
Neutral
MACD (12,26)
-0.45
Sell
ADX (14)
23.59
Neutral
Williams %R
-30.08
Buy
CCI (14)
23.91
Neutral
ATR (14)
0.54
-
Ultimate Oscillator
54.19
Neutral
ROC
1.87
Buy
iTeos Therapeutics’s (ITOS) Relative Strength Index (RSI) is 44.92, creating a Neutral signal.
iTeos Therapeutics’s (ITOS) Trend Strength Indicator (ADX) is 23.59, creating a Neutral signal.
iTeos Therapeutics’s (ITOS) Commodity Channel Index (CCI) is 23.91, creating a Neutral signal.
iTeos Therapeutics’s (ITOS) Price Rate of Change (ROC) is 1.87, creating a Buy signal.

FAQ

Is ITOS a Buy, Hold, or Sell?
Based on ITOS’s technical indicators, ITOS is a Hold.
    What is ITOS’s RSI (14)?
    ITOS’s RSI (14) is 44.92, which suggests ITOS is a Neutral.
      What is ITOS’s MACD?
      ITOS’s MACD is -0.45, which suggests ITOS is a Sell.
        What is ITOS’s 5-day moving average?
        ITOS’s 5-day moving average is 9.21, which suggests ITOS is a Buy.
          What is ITOS’s 20-day moving average?
          ITOS 20-day moving average is 9.07, which suggests ITOS is a Buy.
            What is ITOS’s 50-day moving average?
            ITOS’s 50-day moving average is 10.99, which suggests ITOS is a Sell.
              What is ITOS’s 200-day moving average?
              ITOS’s 200-day moving average is 13.14, which suggests ITOS is a Sell.
                What is ITOS’s Williams % R (14)?
                ITOS’s Williams % R (14) is -30.08, which suggests ITOS is a Buy.
                  What is ITOS’s CCI (14)?
                  ITOS’s CCI (14) is 23.91, which suggests ITOS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis